HOYA Corporation (HOCPY)
USD 126.16
(3.64%)
USD 126.16
(3.64%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 606.3 Billion JPY | -4.04% |
| 2022 | 631.85 Billion JPY | 11.38% |
| 2021 | 567.28 Billion JPY | 19.43% |
| 2020 | 474.97 Billion JPY | -2.69% |
| 2019 | 488.08 Billion JPY | -0.01% |
| 2018 | 488.14 Billion JPY | 6.88% |
| 2017 | 456.71 Billion JPY | 10.77% |
| 2016 | 412.29 Billion JPY | -3.03% |
| 2015 | 425.15 Billion JPY | 5.15% |
| 2014 | 404.35 Billion JPY | 17.64% |
| 2013 | 343.7 Billion JPY | 2.83% |
| 2012 | 334.25 Billion JPY | 7.87% |
| 2011 | 309.87 Billion JPY | -3.36% |
| 2010 | 320.63 Billion JPY | 77.69% |
| 2009 | 180.44 Billion JPY | -4.98% |
| 2008 | 189.9 Billion JPY | -13.16% |
| 2007 | 218.68 Billion JPY | 13.5% |
| 2006 | 192.68 Billion JPY | 11.9% |
| 2005 | 172.19 Billion JPY | 14.68% |
| 2004 | 150.14 Billion JPY | 16.61% |
| 2003 | 128.76 Billion JPY | 13.93% |
| 2002 | 113.01 Billion JPY | 11.89% |
| 2001 | 101 Billion JPY | -0.47% |
| 2000 | 101.48 Billion JPY | 18.32% |
| 1999 | 85.77 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 115.8 Billion JPY | -26.46% |
| 2023 Q2 | 168.68 Billion JPY | 2.22% |
| 2023 Q4 | 157.47 Billion JPY | -9.89% |
| 2023 FY | 606.3 Billion JPY | -4.04% |
| 2023 Q1 | 165.02 Billion JPY | 1.96% |
| 2023 Q3 | 174.75 Billion JPY | 3.6% |
| 2022 FY | 631.85 Billion JPY | 11.38% |
| 2022 Q1 | 155.43 Billion JPY | 5.03% |
| 2022 Q2 | 160.13 Billion JPY | 3.02% |
| 2022 Q3 | 154.43 Billion JPY | -3.56% |
| 2022 Q4 | 161.85 Billion JPY | 4.81% |
| 2021 Q1 | 134.05 Billion JPY | 3.61% |
| 2021 Q3 | 146.59 Billion JPY | 5.74% |
| 2021 Q4 | 147.98 Billion JPY | 0.95% |
| 2021 FY | 567.28 Billion JPY | 19.43% |
| 2021 Q2 | 138.64 Billion JPY | 3.42% |
| 2020 Q1 | 97.26 Billion JPY | -13.71% |
| 2020 Q3 | 128.82 Billion JPY | 7.79% |
| 2020 Q4 | 129.38 Billion JPY | 0.43% |
| 2020 FY | 474.97 Billion JPY | -2.69% |
| 2020 Q2 | 119.5 Billion JPY | 22.86% |
| 2019 Q1 | 122.73 Billion JPY | 0.14% |
| 2019 Q2 | 131.24 Billion JPY | 6.94% |
| 2019 Q3 | 121.37 Billion JPY | -7.52% |
| 2019 Q4 | 112.72 Billion JPY | -7.13% |
| 2019 FY | 488.08 Billion JPY | -0.01% |
| 2018 Q3 | 125.46 Billion JPY | 2.82% |
| 2018 Q1 | 118.1 Billion JPY | 2.57% |
| 2018 Q2 | 122.01 Billion JPY | 3.32% |
| 2018 Q4 | 122.56 Billion JPY | -2.31% |
| 2018 FY | 488.14 Billion JPY | 6.88% |
| 2017 Q2 | 115 Billion JPY | 6.07% |
| 2017 FY | 456.71 Billion JPY | 10.77% |
| 2017 Q4 | 115.14 Billion JPY | -2.55% |
| 2017 Q1 | 108.42 Billion JPY | 3.18% |
| 2017 Q3 | 118.15 Billion JPY | 2.74% |
| 2016 Q1 | 98.67 Billion JPY | -3.64% |
| 2016 Q2 | 104.45 Billion JPY | 5.85% |
| 2016 Q3 | 104.09 Billion JPY | -0.34% |
| 2016 FY | 412.29 Billion JPY | -3.03% |
| 2016 Q4 | 105.07 Billion JPY | 0.95% |
| 2015 Q2 | 111.77 Billion JPY | 6.22% |
| 2015 FY | 425.15 Billion JPY | 5.15% |
| 2015 Q4 | 102.4 Billion JPY | -3.18% |
| 2015 Q3 | 105.76 Billion JPY | -5.38% |
| 2015 Q1 | 105.22 Billion JPY | 0.37% |
| 2014 Q1 | 94.38 Billion JPY | 2.17% |
| 2014 Q2 | 99.83 Billion JPY | 5.77% |
| 2014 FY | 404.35 Billion JPY | 17.64% |
| 2014 Q3 | 105.3 Billion JPY | 5.47% |
| 2014 Q4 | 104.83 Billion JPY | -0.44% |
| 2013 FY | 343.7 Billion JPY | 2.83% |
| 2013 Q4 | 92.38 Billion JPY | 3.51% |
| 2013 Q3 | 89.25 Billion JPY | 9.12% |
| 2013 Q2 | 81.79 Billion JPY | 1.78% |
| 2013 Q1 | 80.36 Billion JPY | -9.0% |
| 2012 Q4 | 88.31 Billion JPY | 17.51% |
| 2012 Q1 | 88.88 Billion JPY | 17.64% |
| 2012 FY | 334.25 Billion JPY | 7.87% |
| 2012 Q2 | 80.86 Billion JPY | -9.02% |
| 2012 Q3 | 75.15 Billion JPY | -7.06% |
| 2011 FY | 309.87 Billion JPY | -3.36% |
| 2011 Q1 | 81.65 Billion JPY | 1.74% |
| 2011 Q2 | 80.09 Billion JPY | -1.91% |
| 2011 Q3 | 68.71 Billion JPY | -14.21% |
| 2011 Q4 | 75.55 Billion JPY | 9.96% |
| 2010 Q1 | 50.84 Billion JPY | 8.77% |
| 2010 FY | 320.63 Billion JPY | 77.69% |
| 2010 Q4 | 80.25 Billion JPY | 63.85% |
| 2010 Q3 | 48.98 Billion JPY | 1.82% |
| 2010 Q2 | 48.1 Billion JPY | -5.39% |
| 2009 FY | 180.44 Billion JPY | -4.98% |
| 2009 Q4 | 46.75 Billion JPY | -3.18% |
| 2009 Q3 | 48.28 Billion JPY | 1.48% |
| 2009 Q2 | 47.58 Billion JPY | 25.76% |
| 2009 Q1 | 37.83 Billion JPY | 26.59% |
| 2008 Q4 | 29.88 Billion JPY | -37.79% |
| 2008 Q3 | 48.03 Billion JPY | -12.22% |
| 2008 Q2 | 54.72 Billion JPY | -4.42% |
| 2008 Q1 | 57.25 Billion JPY | -1.22% |
| 2008 FY | 189.9 Billion JPY | -13.16% |
| 2007 Q4 | 57.96 Billion JPY | -12.8% |
| 2007 Q3 | 66.46 Billion JPY | 36.78% |
| 2007 Q1 | 45.65 Billion JPY | 0.0% |
| 2007 Q2 | 48.59 Billion JPY | 6.44% |
| 2007 FY | 218.68 Billion JPY | 13.5% |
| 2006 FY | 192.68 Billion JPY | 11.9% |
| 2005 FY | 172.19 Billion JPY | 14.68% |
| 2004 FY | 150.14 Billion JPY | 16.61% |
| 2003 FY | 128.76 Billion JPY | 13.93% |
| 2002 FY | 113.01 Billion JPY | 11.89% |
| 2001 FY | 101 Billion JPY | -0.47% |
| 2000 FY | 101.48 Billion JPY | 18.32% |
| 1999 FY | 85.77 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | -35683350.189% |
| Ansell Limited | 624.8 Million USD | -96939.052% |
| Ansell Limited | 624.8 Million USD | -96939.052% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 113.94 Million USD | -532012.946% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -448928114.431% |
| Psykey, Inc. | 415.97 Thousand USD | -145753501.169% |
| ConvaTec Group Plc | 1.2 Billion USD | -50294.654% |
| ConvaTec Group Plc | 1.17 Billion USD | -51508.784% |
| Encision Inc. | 3.13 Million USD | -19333680.192% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 794.01 Thousand USD | -76358851.302% |
| LifePoint, Inc. | -71.35 Thousand USD | 849659563.55% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 462824527.481% |
| Paradigm Medical Industries, Inc. | 525 Thousand USD | -115485614.286% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 603.24 Thousand USD | -100507160.792% |
| Reflect Scientific, Inc. | 596.42 Thousand USD | -101656280.309% |
| SmileDirectClub, Inc. | 275.84 Million USD | -219695.756% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | -67212.15% |
| SheerVision, Inc. | 2.17 Million USD | -27864116.748% |
| United Health Products, Inc. | -4857.00 USD | 12483014306.3% |
| Vasamed, Inc. | -69.38 Thousand USD | 873782310.18% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | -226516078.926% |
| Yubo International Biotech Limited | 52.65 Thousand USD | -1151523108.995% |